When you or your company are targeted for a congressional investigation, you confront a unique challenge. An investigation can present legal, reputational and business risks—both in the immediate congressional arena and in collateral venues, including private civil actions and criminal or civil investigations on the federal or state level.
Navigating the obscure rules and legislative precedents of congressional investigations, along with the individual personalities and interests of members of Congress, requires a blend of legal and political skill steeped in decades of practical experience. Drawing on that skill and experience, we tailor our approach to fit your circumstances, going beyond the strategies and tactics typically deployed in a courtroom or before a regulatory agency.
Our priority is helping you succeed, and we use our understanding of your goals to balance legal, political and financial risks in our advice. In creating an actionable strategy, we chart a path that leverages every advantage from the procedural and substantive protections provided by congressional rules, customs and traditions.
Our team has represented corporations and individuals spanning every industry before almost every committee in Congress, including:
Senate Permanent Subcommittee on Investigations (of the Committee on Homeland Security and Governmental Affairs)
Senate Committee on Finance
Senate Judiciary Committee
Senate Select Committee on Intelligence
Senate Committee on Health, Education, Labor and Pensions
Senate Committee on Homeland Security and Governmental Affairs
Senate Select Committee on Ethics
Senate Special Committee on Aging
House Committee on Energy and Commerce
House Committee on Oversight and Government Reform
House Committee on Financial Services
House Permanent Select Committee on Intelligence
House Ways and Means Oversight Subcommittee
House Committee on Science, Space and Technology
House Select Subcommittee on the Coronavirus Crisis
Represented a leading e-cigarette company in a highly publicized and politically charged House Committee on Energy and Commerce investigation and hearing.
Represented one of the largest for-profit health insurers and a large nonprofit Blue Cross company regarding healthcare and insurance issues before the House Committee on Energy and Commerce, the House Committee on Oversight and Reform and the Senate Committee on Commerce, Science and Transportation.
Represented Fortune 500 corporations being questioned about the companies’ tax strategies before the Senate Permanent Subcommittee on Investigations. Clients included one of the two largest oil companies, one of the two leading US soft drink and consumer product companies, one of the largest US computer service and hardware companies, one of the biggest providers of Internet equipment in the US and one of the largest US pharmaceutical companies.
Represented a high-ranking executive of a Swiss bank in an international tax investigation conducted by the Senate Permanent Subcommittee on Investigations.
Represented a major international financial services company in regard to alternative energy-related investments, House Energy & Commerce Committee.
Represented a major defense contractor during an investigation by the House Committee on Oversight and Reform that lasted several years and included extensive document production and a series of congressional hearings.
Represented a nationally recognized university before the Senate Permanent Subcommittee on Investigations and the Senate Finance Committee.
Represented a national research association in an investigation by the House Committee on Science, Space and Technology relating to the handling of classified information.
Represented a federal government contractor that conducted security background checks and investigations for the Office of Personnel Management in multiple congressional inquiries.
Represented a high-profile energy company before the House Committee on Energy and Commerce and other committees.
Represented various healthcare insurers in a series of congressional investigations, including prescription drug pricing and prescribing practices, surgeons conducting multiple simultaneous surgeries, opioid reimbursement practices and compliance with policies under the Affordable Care Act.
Represented a generic pharmaceutical company in a congressional investigation relating to the price of prescription drugs and subsequent allegations of price fixing, resulting in significant media attention, a criminal investigation by the US Department of Justice, civil investigations by 49 State Attorneys General and multiple class-action lawsuits.
Represented a government contractor before the House Subcommittee on the Coronavirus Crisis relating to procurement of personal protective equipment during the coronavirus pandemic.
A diverse, global network of industry-leading talent committed to you and your vision.